Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s DiseaseFelipe Salech, María Isabel Behrens|Frontiers in Aging Neuroscience|2020Cited by 85